Cargando…

XPO7 is a tumor suppressor regulating p21(CIP1)-dependent senescence

Senescence is a key barrier to neoplastic transformation. To identify senescence regulators relevant to cancer, we screened a genome-wide shRNA library. Here, we describe exportin 7 (XPO7) as a novel regulator of senescence and validate its function in telomere-induced, replicative, and oncogene-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Innes, Andrew J., Sun, Bin, Wagner, Verena, Brookes, Sharon, McHugh, Domhnall, Pombo, Joaquim, Porreca, Rosa María, Dharmalingam, Gopuraja, Vernia, Santiago, Zuber, Johannes, Vannier, Jean-Baptiste, García-Escudero, Ramón, Gil, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919420/ https://www.ncbi.nlm.nih.gov/pubmed/33602872 http://dx.doi.org/10.1101/gad.343269.120

Ejemplares similares

Senescence and aging: Causes, consequences, and therapeutic avenues
por: McHugh, Domhnall, et al.
Publicado: (2018)

CRISPR-based screening identifies XPO7 as a positive regulator of senescence
por: Li, Lan-Zhu, et al.
Publicado: (2023)

Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types
por: Khan, Munazza, et al.
Publicado: (2018)

Cardiac glycosides are broad-spectrum senolytics
por: Guerrero, Ana, et al.
Publicado: (2019)

Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence
por: Aarts, Marieke, et al.
Publicado: (2017)

SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer
por: Tordella, Luca, et al.
Publicado: (2016)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells
por: Georgilis, Athena, et al.
Publicado: (2018)

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
por: Nakayama, Robert, et al.
Publicado: (2016)

TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1)
por: Liu, Yuhui, et al.
Publicado: (2013)

Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
por: Long, Huideng, et al.
Publicado: (2023)

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
por: Phalke, Sameer, et al.
Publicado: (2012)

Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
por: Azmi, Asfar S., et al.
Publicado: (2017)

XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction
por: García-Manzanares, María, et al.
Publicado: (2019)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

XPO1-dependent nuclear export as a target for cancer therapy
por: Azizian, Nancy G., et al.
Publicado: (2020)

Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma
por: Li, Jiao, et al.
Publicado: (2022)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

The ING tumor suppressors in cellular senescence and chromatin
por: Ludwig, Susann, et al.
Publicado: (2011)

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
por: Herranz, Nicolás, et al.
Publicado: (2015)

Xpo7 is a broad-spectrum exportin and a nuclear import receptor
por: Aksu, Metin, et al.
Publicado: (2018)

XPO5 promotes primary miRNA processing independently of RanGTP
por: Wang, Jingjing, et al.
Publicado: (2020)

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
por: Sexton, Rachel, et al.
Publicado: (2019)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma
por: Sellin, Mark, et al.
Publicado: (2022)

Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors
por: Trkulja, Kyla L., et al.
Publicado: (2023)

Effects of Carbonyl Iron Powder (CIP) Content on the Electromagnetic Wave Absorption and Mechanical Properties of CIP/ABS Composites
por: Lai, Wenwen, et al.
Publicado: (2020)

ACTL6A suppresses p21(Cip1) tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype
por: Shrestha, Suruchi, et al.
Publicado: (2021)

XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose
por: Crochiere, Marsha L., et al.
Publicado: (2017)

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia
por: Guillem, Flavia, et al.
Publicado: (2019)

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
por: Wu, Shan, et al.
Publicado: (2020)

Association of XPO1 Overexpression with NF-κB and Ki67 in Colorectal Cancer
por: Aladhraei, Mohammed, et al.
Publicado: (2019)

Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
por: Gargantilla, Marta, et al.
Publicado: (2021)

Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
por: Wang, Huming, et al.
Publicado: (2023)

Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
por: Binder, Adam F., et al.
Publicado: (2023)

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
por: Slebos, R. J., et al.
Publicado: (1996)

TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
por: Meyer, Rosana D., et al.
Publicado: (2017)

HOCTAR database: A unique resource for microRNA target prediction
por: Gennarino, Vincenzo Alessandro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d665o2ajvm4qdgvs7roai3nkbg